HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.054023v1 49/11/1869    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harel, F. Articles by Dupuis, J. Search for Related Content PubMed PubMed Citation Articles by Harel, F. Articles by Dupuis, J.

Use of Adrenomedullin Derivatives for Molecular Imaging of Pulmonary Circulation

¹ Research Center, Montreal Heart Institute/Université de Montréal, Montreal, Quebec, Canada; ² Department of Radiology, Université de Montréal, Montreal, Quebec, Canada; ³ Institut National de la Recherche Scientifique-Institut Armand Frappier, Pointe-Claire, Quebec, Canada; and ⁴ Department of Medicine, Université de Montréal, Montreal, Quebec, Canada

Correspondence: For correspondence or reprints contact: Jocelyn Dupuis, Research Center, Montreal Heart Institute, 5000 Bélanger St., Montreal, Quebec, Canada H1T 1C8. E-mail: jocelyn.dupuis{at}bellnet.ca

Currently, there is no low-molecular-weight agent for imaging of the pulmonary circulation. Adrenomedullin (AM) is a peptide predominantly cleared by the pulmonary circulation through specific endothelial receptors. We developed human AM derivatives radiolabeled with ^99mTc and evaluated their biodistribution, plasma kinetics, and utility as pulmonary vascular imaging agents. Methods: Two derivatives radiolabeled with ^99mTc were evaluated: the natural cyclic form of the peptide, to which the chelator diethylenetriaminepentaacetic acid was added (C-DTPA-AM), and the linear form, which allows direct labeling (L-AM). The compounds were injected into dogs, and the activities of the tracers in blood and in organs were determined with a nuclear medicine camera. Single-pass pulmonary clearance was measured by the indicator dilution technique. The capacity to image perfusion defects was evaluated after surgical pulmonary artery ligation. Results: Both derivatives were rapidly cleared from plasma, with elimination half-lives of 42 and 32 min for C-DTPA-AM and L-AM, respectively. The lungs retained most of the activity after 30 min; this activity was higher (P = 0.02) for L-AM (42% ± 5% [mean ± SEM]) than for C-DTPA-AM (27% ± 1%). Lung activity slowly declined over time but was maintained after 2 h at approximately 20% for both tracers. The single-pass pulmonary clearance of plasma L-AM was 414 ± 85 mL/min. There was a higher level of urinary excretion of L-AM than of C-DTPA-AM. After pulmonary artery ligation, perfusion defects were easily detectable by external imaging. Conclusion: AM derivatives are promising compounds for molecular imaging of the pulmonary circulation. L-AM displayed higher levels of initial lung retention and of kidney excretion.

Key Words: radiopharmaceutical • peptide • receptor • biodistribution • lung

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				J. Dupuis, F. Harel, Y. Fu, Q. T. Nguyen, M. Letourneau, A. Prefontaine, and A. Fournier Molecular Imaging of Monocrotaline-Induced Pulmonary Vascular Disease with Radiolabeled Linear Adrenomedullin J. Nucl. Med., July 1, 2009; 50(7): 1110 - 1115. [Abstract] [Full Text] [PDF]